1. A28 CHARACTERIZING THE ROLE OF NR4A1 IN THE REGULATION OF INTESTINAL SMOOTH MUSCLE CELL PHENOTYPE AND FUNCTION. (4th March 2021) Authors: Szczepanski, H E; Flannigan, K L; Mainoli, B; Alston, L; Lee, J; Baruta, G M; Venu, V P; Shearer, J; Dufour, A; Hirota, S A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 4(2021)Supplement 1 Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A32 THE REGULATION OF INTESTINAL SMOOTH MUSCLE CELL PROLIFERATION IN CROHN'S DISEASE – IS NR4A1 A NOVEL TARGET TO TREAT FIBROSTENOSIS?. (26th February 2020) Authors: Szczepanski, H; Tsai, Y; Venu, V P; Alston, L; Hirota, S A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 3:Supplement 1(2020) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A87 ACTIVATION OF NR4A1 REDUCES INFLAMMATION-ASSOCIATED INTESTINAL FIBROSIS AND DAMPENS FIBROGENIC SIGNALING IN INTESTINAL MYOFIBROBLASTS. (15th March 2019) Authors: Venu, V P; Alston, L; Szczepanski, H; Hirota, S A Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 2(2019)Supplement 2 Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗